Revised: 8 December  2025

Consultations

Outcome of Consultation Topics

Information on the outcomes of recent consultations.

Date Outcome of consultation topic
8 December 2025 Outcome on Proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Bioequivalence of medicines (PDF, 17 pages, 284 KB) 
24 June 2025 Outcome of the consultation on the proposal to change the regulatory and funding restrictions for stimulant treatments for ADHD
24 June 2024 Clozapine Survey/Consultation 2023
11 April 2024 Outcome of the consultation on standards for contraceptive devices in New Zealand
20 March 2024 Outcome of the consultation on the proposed updates to the Guideline on the Regulation of Therapeutic Products in New Zealand: Pharmacovigilance
16 February 2023 Outcome of the consultation on the proposed warning and advisory statements for ocular decongestants for eye redness and/or minor eye irritation
13 July 2022 Outcome of the consultation on the proposed warning and advisory statements relating to the harm of opioid abuse
27 June 2022 Outcome of the consultation on the proposed warning and advisory statements relating to the harm of long-term use and overuse of stimulant laxatives
13 May 2022 Review of Fees payable under the Medicines Act 1981 (PDF, 24 pages, 456 KB)
12 April 2021 Outcome of the consultation on the Plan to update the New Zealand Code of Good Manufacturing Practice PIC/S Guide PE009-8 to PE009-14
29 March 2021 Outcome of the consultation on the proposed changes to paracetamol warning and advisory statements
14 September 2020 Outcome of the consultation on the proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions
1 October 2019 Changes to the prescribing restrictions of riluzole
27 June 2019 Outcome of consultation on the revision of CMN Form B
18 March 2019 Outcome of the consultation on the proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products
1 December 2018 Outcome of consultation on updating the guidance document 'How to change the legal classification of a medicine in New Zealand'
8 November 2018 Outcome of the consultation on the Update to the Guideline on the Regulation of Therapeutic Products – Part 11: Clinical Trials
25 May 2018 Outcome of review of fees payable under the Medicines Regulations 1984
27 October 2017 Outcome of consultation on changes to the Label Statements Database for sedating antihistamines available without a prescription
26 September 2017 Outcome of consultation on change to warning statements on labels of oral non-steroidal anti-inflammatory drugs (NSAIDs) available without a prescription
1 June 2017 Outcome of consultation on addition of warning statements on labels of topical miconazole containing medicines available without prescription
12 May 2017 Outcome of consultation on proposal to change the warning statement on labels of OTC loratadine and desloratadine medicines
11 November 2016 Outcome of consultation on the proposed changes to the data sheet format
2 September 2015 Outcome of consultation on the proposed New Zealand Medicines and Medical Devices Recall Code
31 August 2015 Outcome of consultation on the proposed Guideline on the Regulation of Therapeutic Products in New Zealand. Part 8: Pharmacovigilance
19 August 2015 Outcome of consultation on the proposed addition of warning statements on labels of OTC oral and topical diclofenac medicines
28 May 2015 Proposed amendment to the Medicine Regulations 1984 re fluoride in drinking water. Report of analysis for submission and final decisions
13 March 2015 Proposed amendment to the Medicine Regulations 1984 re fluoride in drinking water
7 August 2014 Response to requests for increased transparency regarding MAAC processes
9 July 2014 Outcome of consultation on Medsafe's proposed change to evaluation administrative processes
23 June 2014 Outcome of consultation on the planned changes to the Label Statements Database for codeine-containing medicines - REVISED
21 May 2014 Outcome of consultation on the proposed revision of the abbreviated process policy
2 May 2014 Outcome of consultation on the planned changes to the prescribing restrictions for clozapine
27 March 2014 Outcome of consultation on the proposed planned changes to the Label Statements Database for aspirin
27 March 2014 Outcome of consultation on the planned removal of warning statements from the Label Statements Database for loratadine and cetirizine
5 February 2014 Medsafe’s consultation with the therapeutic products industry on improving communication
8 January 2014 Standards for contraceptive devices supplied in New Zealand - Summary of consultation
1 July 2013 Planned changes to packaging requirements for antidepressants
22 May 2013 Trans-Tasman early warning system of safety concerns with medicines and medical devices
24 April 2013 Proposed changes to GMP evidence required for active pharmaceutical ingredients
15 March 2013 Over-the-counter (OTC) medicines business process reforms
30 September 2012 Proposed business rule for publication of data sheets
21 October 2010 Revision of the New Zealand good clinical research practice guideline
7 May 2010 Proposal to widen prescriber access to clozapine
11 December 2009 Submission and publication processes for data sheets and consumer medicine information (CMI) on the Medsafe website
19 June 2009 Proposed changes to fees payable under the Medicines Regulations 1984
19 June 2009 Changes to the Medsafe's administrative processes and fees effective 1 July 2009
21 April 2009 Review of the abbreviated evaluation process (Word 39 KB, 5 pages)
4 March 2009 Draft guideline for the transfer of analytical procedures
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /